Development and Customization of a Color-Coded Microbeads-Based Assay for Drug Resistance in HIV-1 Reverse Transcriptase

• Lijun Gu,

  Affiliations Research Center for Asian Infectious Diseases, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan, Japan-China Joint Laboratory of Molecular Immunology and Molecular Microbiology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P. R. China

  ⨯
• Ai Kawana-Tachikawa,

  Affiliation Division of Infectious Diseases, Advanced Clinical Research Center, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan

  ⨯
• Teiichiro Shiino,

  Affiliation AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan

  ⨯
• Hitomi Nakamura,

  Affiliations Department of Infectious Disease Control, International Research Center for Infectious Diseases, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan, Division of Infectious Diseases and Applied Immunology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Michiko Koga,

  Affiliations Division of Infectious Diseases, Advanced Clinical Research Center, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan, Division of Infectious Diseases and Applied Immunology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Tadashi Kikuchi,

  Affiliations Division of Infectious Diseases, Advanced Clinical Research Center, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan, Division of Infectious Diseases and Applied Immunology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Eisuke Adachi,

  Affiliation Division of Infectious Diseases and Applied Immunology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Tomohiko Koibuchi,

  Affiliation Division of Infectious Diseases and Applied Immunology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Takaomi Ishida,

  Affiliations Research Center for Asian Infectious Diseases, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan, Japan-China Joint Laboratory of Molecular Immunology and Molecular Microbiology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P. R. China

  ⨯
• George F. Gao,

  Affiliation CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P. R. China

  ⨯
• Masaki Matsushita,

  Affiliation Biotech Research and Development, Wakunaga Pharmaceutical Corporation, Hiroshima, Japan

  ⨯
• Wataru Sugiura,

  Affiliation AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan

  ⨯
• Aikichi Iwamoto,

  Affiliations Research Center for Asian Infectious Diseases, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan, Division of Infectious Diseases, Advanced Clinical Research Center, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan, Department of Infectious Disease Control, International Research Center for Infectious Diseases, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan, Division of Infectious Diseases and Applied Immunology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Noriaki Hosoya

  * E-mail: hnori@ims.u-tokyo.ac.jp

  Affiliations Division of Infectious Diseases, Advanced Clinical Research Center, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan, Department of Infectious Disease Control, International Research Center for Infectious Diseases, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan

  ⨯